Epivir HBV and Insulin degludec and liraglutide Subcutaneous
Determining the interaction of Epivir HBV and Insulin degludec and liraglutide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lamivudine
Brand name: Epivir, Epivir HBV
Synonyms: Epivir-HBV
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Epivir HBV-Insulin degludec Subcutaneous
- Epivir HBV-Insulin detemir
- Epivir HBV-Insulin Detemir (Cartridges and Prefilled Syringes)
- Epivir HBV-Insulin Detemir (Vials)
- Epivir HBV-Insulin detemir Subcutaneous
- Epivir HBV-Insulin glargine
- Insulin degludec and liraglutide Subcutaneous-Epivir-HBV (Lamivudine Oral Solution)
- Insulin degludec and liraglutide Subcutaneous-Epivir-HBV (Lamivudine Tablets)
- Insulin degludec and liraglutide Subcutaneous-Eplerenone
- Insulin degludec and liraglutide Subcutaneous-Epoetin alfa
- Insulin degludec and liraglutide Subcutaneous-Epoetin alfa Injection
- Insulin degludec and liraglutide Subcutaneous-Epoetin Alfa Vials